| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 08/12/2003 | US6605289 Topically administering composition consisting of water, stannous fluoride, and zinc gluconate in amount sufficient to prevent oxidation and hydrolysis of stannous ion for at least three months to animal afflicted with fungal infection |
| 08/07/2003 | WO2003065392A2 Photovoltaic cell interconnection |
| 08/07/2003 | WO2003064009A1 Portable oxygen concentrator |
| 08/07/2003 | WO2003063900A1 Process for the preparation of a nutrient formulation |
| 08/07/2003 | WO2003063848A1 Lutein/zeaxanthin for glare protection |
| 08/07/2003 | WO2003063840A2 Transmucosal delivery of proton pump inhibitors |
| 08/07/2003 | WO2003063795A2 Compositions and methods for treating diarrhea |
| 08/07/2003 | WO2003052091A8 Growth factor modified protein matrices for tissue engineering |
| 08/07/2003 | US20030149106 For use in moisturizing compositions (e.g., moisturizing skin treatments) to which medical adhesives will adhere, in tissue antiseptic preparations, in personal care forumulation such as cosmetics, and in drug delivery forumulations |
| 08/07/2003 | US20030148946 Method and compositions for preventing hormone induced adverse effects |
| 08/07/2003 | US20030147970 Substantially non-colloidal solution made by combining ingredients comprising (a) water; (b) a source of free silver ions; and (c) a substantially non-toxic, substantially thiol-free, substantially water-soluble complexing agent. |
| 08/07/2003 | US20030147945 Vehicles stably associated with non-antagonistic combinations of >/= 2 synergistic agents |
| 08/07/2003 | US20030147942 Pharmaceutical gel composition |
| 08/07/2003 | CA2514518A1 Process for the preparation of a nutrient formulation |
| 08/07/2003 | CA2474487A1 Photovoltaic cell interconnection |
| 08/07/2003 | CA2472103A1 Transmucosal delivery of proton pump inhibitors |
| 08/06/2003 | EP1333274A2 Up-converting reporters for biological and other assays using laser excitation techniques |
| 08/06/2003 | EP1332751A1 Use of olive oil in the preparation of a product for oral hygiene for eliminating or reducing bacterial plaque and/or bacteria in the mouth |
| 08/06/2003 | EP1331947A2 Use of citric acid as antimicrobial agent or enhancer or as anticancer agent |
| 08/06/2003 | EP1331945A2 Otic microbial combinations for treatment of animals with ruptured tympanic membrane |
| 08/06/2003 | EP1331919A2 Dental composition for hypersensitive teeth |
| 08/06/2003 | EP1331902A2 Improved ophthalmic and contact lens solutions containing forms of vitamin b |
| 08/06/2003 | EP1173187B1 Combined preparations comprising morpholine anthracyclines and platinum derivatives |
| 08/06/2003 | EP0690718B1 Peritoneal dialysis solutions containing maltodextrins and amino acids |
| 08/06/2003 | CN1434707A Method and compositions for preventing hormone induced adverse effects |
| 08/06/2003 | CN1433792A Traditional Chinese medicine for treating child pneumonia |
| 08/06/2003 | CN1433777A Cerium carried (Ôàó) rectorite anti-inflammatory and bacteriostatic medicine and preparation process thereof |
| 08/06/2003 | CN1433776A Process for preparing colloidal silver solution |
| 08/06/2003 | CN1433750A Meerschaum toothpaste and preparation process thereof |
| 08/06/2003 | CN1116890C Medicine for treating hepatitis B |
| 08/06/2003 | CN1116884C Capsule for treating angiocardiopathy, cholecystitis and cholelithiasis |
| 08/06/2003 | CN1116870C Applicatino of preventing and treating peripheral neurophathy by administering selegiline |
| 08/05/2003 | US6602906 Method for delivering ascorbic acid and acetone to the dermal layer of the skin |
| 08/05/2003 | US6602870 Synergistic antitumor mixture of tegafur, uracil and folinic acid to potentiate coadministered oxaliplatin; colorectal cancer |
| 08/05/2003 | US6602670 Treating tumors; obtain tissue sample, isolate nucleotide sequences, amplify nucleotide sequences, monitor nucleotide sequence concentration of marker gene, compare to control |
| 08/05/2003 | US6602442 Composition for generating chlorine dioxide |
| 08/05/2003 | US6601580 Enhancing therapeutic effectiveness of nitric oxide inhalation |
| 08/05/2003 | CA2089148C Oxidized complex comprising water-soluble carboxypolysaccaride and magnetic iron oxide |
| 07/31/2003 | WO2003062149A2 Antimicrobial composition including a triamine and a biocide |
| 07/31/2003 | WO2003061766A1 Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne |
| 07/31/2003 | WO2003061676A1 Compositions for and method of treatment for skin ailments |
| 07/31/2003 | WO2003061588A2 Method of increasing fertility and athletic performance in horses |
| 07/31/2003 | WO2003061584A2 Novel substituted benzimidazole dosage forms and method of using same |
| 07/31/2003 | WO2003061574A2 Prevention of cisplatin induced deafness |
| 07/31/2003 | WO2003061556A2 Ingestible capsaicin neutralizer |
| 07/31/2003 | WO2003061389A1 Antiseptic compositions and methods |
| 07/31/2003 | WO2003041703A3 Use of a flavonoid for the treatment of burns |
| 07/31/2003 | WO2003028696A3 Compositions for delivery of drug combinations |
| 07/31/2003 | WO2002015895A3 Alpha-difluoromethylornithine (dfmo) use in the human prostate |
| 07/31/2003 | WO2002004003A3 Composition for the treatment of osteoarthritis |
| 07/31/2003 | US20030144306 A liquid oral composition comprising a proton pump inhibitor, e,g, omeprazole, lansoprazole,and a buffer; can also contain a parietal cell activator; acid resistance; side effect reduction; kits; drug delivery; Zollinger-Ellison syndrome |
| 07/31/2003 | US20030143293 Compositions and methods for treating diarrhea |
| 07/31/2003 | US20030143291 Herbal compositions and methods for diabetes and weight loss management. |
| 07/31/2003 | US20030140959 Photovoltaic cell interconnection |
| 07/31/2003 | DE20305898U1 Pharmaceutical compositions include vitamins and optionally trace elements to enhance the therapeutic effect and/or reduce the side effects of drugs |
| 07/31/2003 | CA2474058A1 Composition for and method of treatment for skin ailments |
| 07/31/2003 | CA2472564A1 Aqueous antiseptic composition comprising an antimicrobial agent, a high concentration of a hydroxycarboxylic acid buffer, and a cationic film-forming polymer |
| 07/30/2003 | EP1330242A2 Antiproliferative colchicine compositions and uses thereof |
| 07/30/2003 | EP1330226A2 Method for producing purified hematinic iron-saccharidic complex and product produced |
| 07/30/2003 | EP1330164A1 Antibacterial agents, and antibacterial and deodorizing solution comprising the same |
| 07/30/2003 | EP1056442B1 Antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa |
| 07/30/2003 | EP0832198B1 Oxygen activatable formulations for disinfection or sterilization |
| 07/30/2003 | CN1433382A Particle comprising host lattice and guest, its preparation and use in ultravioletlight screening compositions |
| 07/30/2003 | CN1433316A Biologically active agents and drugs |
| 07/30/2003 | CN1433313A Combination of serotonin reuptake inhibitor and 5-HT2C antagonist, inverse agonist or partial agonist |
| 07/30/2003 | CN1433300A Treatment agent |
| 07/30/2003 | CN1432405A Edible fungus with trace elements |
| 07/30/2003 | CN1432392A Wind dispelling and pain relieving ointment |
| 07/30/2003 | CN1432390A External medicine for treating sterility and women's diseases and its prepn |
| 07/30/2003 | CN1432389A Xuerongguyugao ointment for healing fracture and its prepn |
| 07/30/2003 | CN1432384A Ointment for removing necrosis, promoting granulation and invigorating bone and its prepn |
| 07/30/2003 | CN1432377A Plaster for treating rheumatic diseases and psoatic strain and its prepn process |
| 07/30/2003 | CN1432366A Use of mica in preparing medicine |
| 07/30/2003 | CN1116066C Medicine for treating mastopathy by grasping it in palm |
| 07/30/2003 | CN1116065C Plaster for treating ostalgia and its preparing process |
| 07/30/2003 | CN1116046C Injecta for curing primary varix of lower limb |
| 07/30/2003 | CN1116045C Powdered medicine 'kouqingyanhousan' and its preparing process |
| 07/30/2003 | CN1116028C Nano realgar and its preparation |
| 07/29/2003 | US6599532 Controlled release alprazolam in the core optionally in combination with an anti-psychotic agent, in a rapid release external coat; smaller, easier to swallow |
| 07/29/2003 | US6599518 Chemically washing a microbially derived cellulose produced by the bacteria acetobacter xylinum, with sodium hydroxide, dehydrating by applying a water-miscible solvent selected from methanol, ethanol, propanol, and removing the solvent |
| 07/29/2003 | US6599512 Electrolyte content w/o emulsions for treating irritated/sensitive skins |
| 07/29/2003 | US6599498 Enhanced magnetic resonance imaging agent and a hematinic agent; carboxyalkylated reduced polysaccharides coated ultrasmall superparamagnetic iron oxides; carboxymethyl reduced dextran as a plasma extender |
| 07/29/2003 | US6599234 Heating of magnetic material by hysteresis effects |
| 07/29/2003 | CA2189474C Compositions having antiviral properties and preparation process |
| 07/24/2003 | WO2003060034A1 Anion generating material and skin treating agent using the same |
| 07/24/2003 | WO2003059987A1 Multidrop tree branching functional polyethylene glycol, the preparation method and the use of it |
| 07/24/2003 | WO2003059942A2 Peptides and peptidomimetics having anti-proliferative activity and their use |
| 07/24/2003 | WO2003059834A1 Glass-ceramic composite containing nanoparticles |
| 07/24/2003 | WO2003059417A1 Bicarbonate-based solutions for dialysis therapies |
| 07/24/2003 | WO2003059404A2 Preparation for wound healing and prevention of bandage adhesion to the wound |
| 07/24/2003 | WO2003059367A1 A healthful chinese traditional medicinal preparation optimizing the brain |
| 07/24/2003 | WO2003059361A1 Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium |
| 07/24/2003 | WO2003059355A1 Quinazolinone compounds in combined modalities for improved cancer treatment |
| 07/24/2003 | WO2003059263A2 Inorganic nanoparticles to modify the viscosity and physical properties of ophthalmic and otic compositions. |
| 07/24/2003 | WO2003059082A1 Center-filled chewing gum containing calcium |
| 07/24/2003 | WO2003048168A3 Trioxane derivatives as antimalaria or anticancer compounds |
| 07/24/2003 | WO2003041645A3 Method of vaccinating a human patient to prevent metastatic tumors |
| 07/24/2003 | WO2003011309A3 Pharmaceutical composition for treating hypercholesterolaemia |
| 07/24/2003 | WO2002094179A3 Novel topical microbicidal compositions |
| 07/24/2003 | US20030139354 Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases |